Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care
“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention. ”
The fully captioned video and edited transcript will be posted within the next few days.
This COCA Call will be held on Friday, March 27, 2020
For some people, the effects of COVID-19 can last well beyond the immediate illness. Patients and clinicians across the United States are reporting long-term effects of COVID-19, commonly referred to as long COVID. Symptoms may include cognitive difficulties, fatigue, and shortness of breath. In some patients, critical illness from COVID-19 may be the cause of persistent symptoms, but many patients with long-term effects had mild or asymptomatic acute COVID-19 infection. During this COCA Call, presenters will share their firsthand experiences with treating long COVID, focusing on the pulmonary, neurologic, and psychological aspects. They will also describe their experiences with establishing clinics that provide care for patients with these long-term effects.
Alfonso C Hernandez-Romieu, MD, MPH
LCDR, U.S. Public Health Service
Late Sequelae Unit, Clinical Team
Centers for Disease Control and Prevention
Jennifer Possick, MD
Associate Professor, Section of Pulmonary, Critical Care and Sleep Medicine
Department of Internal Medicine
Yale University School of Medicine
Allison Navis, MD
Assistant Professor, Division Neuro-Infectious Diseases
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System
Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
Thursday, January 28, 2021,
2:00 PM – 3:00 PM ET
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
US: +16692545252,,1606808037#,,,,,,0#,,594536# or +16468287666,,1606808037#,,,,,,0#,,594536#
Webinar ID: 160 680 8037Add to Calendar
Advanced registration is not required.
Date: Thursday, January 28, 2021
Time: 2:00 PM – 3:00 PM ET
A few minutes before the webinar begins, please click the link below to join:
Webinar ID: 160 680 8037
Dial-in US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
iPhone one-tap: US: +16692545252,,1600369650# or +16468287666,,1600369650#
International numbers available: https://www.zoomgov.com/u/adQOV17URbexternal icon
At the conclusion of the session, the participant will be able to accomplish the following—
- Identify signs and symptoms of long COVID which occur after the acute phase of SARS-CoV-2 infection.
- Identify potential multidisciplinary teams for patient care.
- Describe common challenges to post-acute COVID-19 care.
- Describe examples of patient-centered, interdisciplinary post-acute COVID-19 care.
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.
Long-Term Effects of COVID-19
Late Sequelae of COVID-19
NIH Workshop on Post-Acute Sequelae of COVID-19
To receive continuing education (CE) for WC2922-012821 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care, Thursday, January 2021, please visit TCEO and follow these 9 Simple Steps by Monday, March 1, 2021.
To receive continuing education (CE) for WD2922-012821 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care, Thursday, January 28, 2021, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by Thursday, March 2, 2023.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-21-014-L04-P and enduring JA4008229-0000-21-015-H04-P course category.
This activity has been designated as Knowledge-Based.
In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.